TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.425$ -3.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Vaxart Inc (VXRT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 165 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VXRT
Line item Q4 16 Q1 17 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
57 47 46 40 35 4.5 57 48 41 35 36 37 43 37 53 64 155 153 206 229 241 221 200 181 175 154 130 123 106 92 89 114 167 166 159 164 209 186 180 165
56 46 46 40 35 3.8 32 26 19 15 15 17 21 18 34 46 136 129 175 189 192 169 154 138 120 99 76 71 57 46 44 72 66 68 63 70 117 136 132 117
38 12 11 18 20 1.6 17 24 18 11 8.4 16 20 14 30 44 133 127 157 165 167 144 123 91 51 44 48 43 33 35 27 43 22 25 29 20 17 54 51 51
49 38 39 39 34 3.0 17 24 18 11 8.4 16 20 14 30 44 133 127 171 185 188 166 148 130 115 94 72 68 53 40 37 63 59 52 42 26 29 64 61 64
4.2 6.6 0.6 0.6 0.1 0.6 13 0.6 0.3 1.8 5.6 0.0 0.6 3.6 2.8 0.2 0.5 0.3 0.7 0.1 0.2 0.1 0.1 5.5 1.9 0.0 0.3 0.0 0.4 3.0 2.3 4.8 3.7 12 16 41 86 51 58 47
2.6 – 0.0 0.0 0.0 – 0.0 0.0 0.0 0.0 0.1 – – 0.0 0.0 0.2 0.0 0.2 0.0 0.0 – 0.0 – – – 2.0 0.0 0.0 0.8 0.0 0.0 – -4.1 – – – – – – –
0.3 0.3 0.2 0.2 0.2 0.2 1.0 1.0 1.1 1.1 1.6 1.5 1.5 0.2 0.2 0.3 3.3 1.5 8.6 4.3 5.4 6.6 7.6 22 12 16 14 14 – – – – – – – – – – – –
– – 0.0 0.0 0.0 – 0.0 0.0 0.0 – – – – – – – – – – – – 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5
0.0 – 0.0 0.0 0.0 0.0 24 21 20 19 19 18 18 17 17 16 16 15 15 14 14 11 10 9.9 9.6 5.0 4.8 4.7 4.5 4.3 4.1 3.9 3.7 3.6 3.4 3.2 3.0 2.8 2.6 2.5
29 23 22 21 21 43 25 25 25 24 24 21 24 24 21 24 23 29 30 29 36 34 34 38 53 43 40 38 34 34 33 34 98 107 113 131 182 98 86 83
11 5.5 5.0 5.9 5.2 4.5 7.8 8.8 8.0 7.5 8.6 7.5 9.2 9.2 7.4 11 10 12 12 13 13 11 11 16 22 18 16 14 11 14 14 16 80 91 99 118 169 87 77 73
0.3 0.3 0.3 0.2 0.2 1.5 1.9 1.8 1.8 1.7 2.4 2.2 3.3 0.8 2.4 4.0 4.7 4.8 3.8 4.9 4.5 1.8 1.9 2.5 3.5 2.3 2.3 2.4 3.9 6.5 5.2 5.6 5.6 7.1 3.3 3.5 3.8 3.0 2.5 2.5
3.4 1.8 4.3 1.4 1.3 1.4 1.7 1.4 1.3 1.0 0.8 0.6 1.0 0.9 0.8 1.2 1.9 2.1 4.6 3.7 3.7 3.9 4.0 5.0 7.9 5.5 3.9 4.2 1.3 1.6 4.0 3.6 2.5 7.0 17 11 53 21 24 17
0.2 0.1 0.0 0.0 0.1 39 3.1 2.7 2.3 1.9 1.6 1.2 – – – – – – – – – – – – – – – – – – – – – – – – – – – –
28 24 19 19 14 -39 31 22 16 11 13 16 19 13 31 40 132 123 176 200 205 188 166 143 122 111 90 85 72 58 56 80 68 59 46 33 27 88 94 82
-153 -158 -158 -164 -169 -80 -78 -87 -93 -98 -99 -105 -110 -117 -118 -127 -135 -149 -165 -181 -199 -219 -244 -274 -303 -327 -352 -375 -392 -410 -434 -450 -465 -477 -492 -507 -515 -460 -455 -469
35 35 – 35 35 35 53 71 71 71 73 146 162 189 171 171 171 171 171 171 171 171 171 126 127 177 177 177 177 177 177 177 177 228 228 228 229 230 242 242

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?